Literature DB >> 15168777

Pulmonary lymphoepithelioma-like carcinoma: predominant infiltration of tumor-associated cytotoxic T lymphocytes might represent the enhanced tumor immunity.

Motohiro Kobayashi1, Makoto Ito, Kenji Sano, Takayuki Honda, Jun Nakayama.   

Abstract

Lymphoepithelioma-like carcinoma (LELC) of the lung is an undifferentiated carcinoma with prominent lymphoid stroma. We encountered a case of synchronous primary lung cancers of LELC and papillary adenocarcinoma in a 67-year-old Japanese woman. By in situ hybridization, Epstein-Barr virus (EBV) genome was detected in malignant epithelial cells of LELC but not in the papillary adenocarcinoma. Tumor-infiltrating lymphocytes in LELC were predominantly CD8+ and T cell intracytoplasmic antigen (TIA-1)+ cytotoxic T cells with closely associated with HLA-DR-positive LELC cells by double immunostaining. These data indicate that the exaggerated lymphoid infiltration in and around the EBV-infected carcinoma cells may represent the enhanced tumor immunity, suggesting a better prognostic indicator.

Entities:  

Mesh:

Year:  2004        PMID: 15168777     DOI: 10.2169/internalmedicine.43.323

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

Review 1.  Pulmonary lymphoepithelioma-like carcinoma with rapid progression.

Authors:  Satona Tanaka; Fengshi Chen; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-15

2.  A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC).

Authors:  G Aurilio; V Ricci; F De Vita; M Fasano; N Fazio; M Orditura; L Funicelli; G De Luca; D Iasevoli; F Iovino; F Ciardiello; G Conzo; F Nolè; Mg Lamendola
Journal:  Ecancermedicalscience       Date:  2010-12-22

3.  Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.

Authors:  S Théoleyre; K Mori; B Cherrier; N Passuti; F Gouin; F Rédini; D Heymann
Journal:  BMC Cancer       Date:  2005-09-27       Impact factor: 4.430

4.  Primary pulmonary lymphoepithelioma-like carcinoma initially diagnosed as squamous metaplasia: A case report and literature review.

Authors:  Yasha Liang; Cheng Shen; Guowei Che; Fengming Luo
Journal:  Oncol Lett       Date:  2015-02-17       Impact factor: 2.967

5.  Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis.

Authors:  Yu Nakanishi; Kakuhiro Yamaguchi; Yusuke Yoshida; Shinjiro Sakamoto; Yasushi Horimasu; Takeshi Masuda; Taku Nakashima; Shintarou Miyamoto; Hiroshi Iwamoto; Shintaro Hirata; Kazunori Fujitaka; Hironobu Hamada; Eiji Sugiyama; Noboru Hattori
Journal:  Intern Med       Date:  2020-06-23       Impact factor: 1.271

6.  Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification.

Authors:  Yanyang Liu; Lang Long; Jiewei Liu; Lingling Zhu; Feng Luo
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

Review 7.  Pathogenic Role of Epstein-Barr Virus in Lung Cancers.

Authors:  David Becnel; Ramsy Abdelghani; Asuka Nanbo; Janardhan Avilala; Jacob Kahn; Li Li; Zhen Lin
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048

Review 8.  Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.

Authors:  Shuting Han; Joshua K Tay; Celestine Jia Ling Loh; Axel Jun Ming Chu; Joe Poh Sheng Yeong; Chwee Ming Lim; Han Chong Toh
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.